BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo K, Lian Y, Zhang M, Yu H, Wang G, Li J. Charge convertible biomimetic micellar nanoparticles for enhanced melanoma-targeted therapy through tumor cells and tumor-associated macrophages dual chemotherapy with IDO immunotherapy. Chemical Engineering Journal 2021;412:128659. [DOI: 10.1016/j.cej.2021.128659] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Bagasariya D, Charankumar K, Shah S, Famta P, Khatri D, Singh Raghuvanshi R, Bala Singh S, Srivastava S. Biomimetic Nanotherapeutics: Employing Nanoghosts to fight Melanoma. Eur J Pharm Biopharm 2022:S0939-6411(22)00137-0. [PMID: 35787429 DOI: 10.1016/j.ejpb.2022.06.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ding M, Fan Y, Lv Y, Liu J, Yu N, Kong D, Sun H, Li J. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy. Acta Biomater 2022:S1742-7061(22)00380-4. [PMID: 35779775 DOI: 10.1016/j.actbio.2022.06.041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Yang Z, Zhang L, Wei J, Li R, Xu Q, Hu H, Xu Z, Ren J, Wong CY. Tumor acidity-activatable photothermal/Fenton nanoagent for synergistic therapy. J Colloid Interface Sci 2022;612:355-66. [PMID: 34998195 DOI: 10.1016/j.jcis.2021.12.134] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
4 Li H, Luo Q, Zhang H, Ma X, Gu Z, Gong Q, Luo K. Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation. Chem Soc Rev 2022. [DOI: 10.1039/d2cs00437b] [Reference Citation Analysis]
5 Chen X, Shuai D, Jiang Z, Yang H, Luo D, Ni H, Wang L, Chen B. Study on the Regulation and Mechanism of the Vanadium Substituted Polyoxometalates of H 6 [P 2 Mo 18 O 62 ] on Melanogenesis of Mouse Melanoma Cell B16. Acta Chimica Sinica 2022;80:116. [DOI: 10.6023/a21110528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Luo K, Gao Y, Yin S, Yao Y, Yu H, Wang G, Li J. Co-delivery of paclitaxel and STAT3 siRNA by a multifunctional nanocomplex for targeted treatment of metastatic breast cancer. Acta Biomater 2021;134:649-63. [PMID: 34289420 DOI: 10.1016/j.actbio.2021.07.029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
7 Lu Y, Xu F, Wang Y, Shi C, Sha Y, He G, Yao Q, Shao K, Sun W, Du J, Fan J, Peng X. Cancer immunogenic cell death via photo-pyroptosis with light-sensitive Indoleamine 2,3-dioxygenase inhibitor conjugate. Biomaterials 2021;278:121167. [PMID: 34624752 DOI: 10.1016/j.biomaterials.2021.121167] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 20.0] [Reference Citation Analysis]
8 Luo K, Xu F, Yao T, Zhu J, Yu H, Wang G, Li J. TPGS and chondroitin sulfate dual-modified lipid-albumin nanosystem for targeted delivery of chemotherapeutic agent against multidrug-resistant cancer. Int J Biol Macromol 2021;183:1270-82. [PMID: 34004196 DOI: 10.1016/j.ijbiomac.2021.05.070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]